31 Jan 2019 --- Royal DSM is set to acquire a 75 percent shareholding in a joint venture with Nenter & Co., Inc in in a move aimed at fulfilling the company’s projected needs for vitamin E. The deal is reportedly set to amount to €135 million (US$155 million). The acquisition will include all of Nenter’s production and related assets for vitamin E in China.